Cellenkos Announces First Patient Dosed with CK0803 Cell The

/PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for...

Related Keywords

Texas , United States , Houston , Neil Shneider , Prnewswire Cellenkos , Tara Sadeghi , Cellenkos Inc , National Institute Of Neurological Disorders , Columbia University , National Clinical Trial , Run In Study , Double Blind , Placebo Control Trial , Amyotrophic Lateral Sclerosis , Associate Professor , Lou Gehrig , Rating Scale Revised , Chief Operating Officer , National Institute , Neurological Disorders , Cellenkos , Nc ,